News & Events

The stem cell therapy developed by MyoPax, a spin-off from the Max Delbrück Center and Charité, could soon be helping children with previously incurable muscle diseases thanks to an accelerated approval process. The necessary clinical trial will start in the fall.

The Berlin competition "Who cycles the most?" has come to a close, with the Max Delbrück Center and the facilities of Campus Buch took third-place. Approximately nine percent of all employees from administration and science participated in the competition, taking to their saddles.

Researchers at BIH and the Max Delbrück Center have developed a new approach for vaccines against coronaviruses using modified spike proteins with lower binding affinity. This method could make vaccinations more effective, the team writes in the "European Journal of Immunology".

Since 2018, Jutta Kramm has headed the communications department at the Max Delbrück Center, and her team is also responsible for “Insights”. Now, the seasoned journalist shares a reading recommendation: a fascinating and moving book about a wondrous creature, the eel, and the big questions of life.

The Arl8b protein provides new insights into the mechanisms underlying Alzheimer’s disease. It also has the potential to function as a diagnostic marker. The scientists behind this discovery, a team led by Erich Wanker from the Max Delbrück Center, have published their findings in “Genome Medicine”.

RNA molecules travel long distances through nerve cells. To reach their destination, they need one thing more than any other – a long life – as a research team led by Marina Chekulaeva from MDC-BIMSB reports in the journal “Molecular Cell.”

There is more to cutting-edge research than pipettes and publications. It is often the inconspicuous everyday processes that influence success or failure. That's why employees who help shape the success of the Max Delbrück Center behind the scenes were once again honored at this year’s summer party.

In late June, Dr. Natalia Alenina and Prof. Michael Bader hosted the conference “Serotonin – 20 Years After” at the Max Delbrück Center. In this interview, they share conference highlights and reveal that this versatile signaling molecule has some surprising functions in the human body – and some that scientists still don’t understand.

Prof. Maike Sander has been serving as the Scientific Director of the Max Delbrück Center since the end of 2022. A conversation with the internationally renowned stem cell and diabetes researcher about networks in science, the research metropolis Berlin and our center as a driver of innovation.